Pictet Asset Management’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $17.5M | Buy |
486,140
+120,930
| +33% | +$4.35M | 0.02% | 540 |
|
|
2025
Q1 | $11.4M | Buy |
365,210
+38,838
| +12% | +$1.21M | 0.01% | 623 |
|
|
2024
Q4 | $8.33M | Sell |
326,372
-16,036
| -5% | -$409K | 0.01% | 713 |
|
|
2024
Q3 | $9.67M | Sell |
342,408
-7,340
| -2% | -$207K | 0.01% | 662 |
|
|
2024
Q2 | $9.22M | Sell |
349,748
-254,997
| -42% | -$6.72M | 0.01% | 643 |
|
|
2024
Q1 | $18.4M | Sell |
604,745
-113,167
| -16% | -$3.44M | 0.02% | 507 |
|
|
2023
Q4 | $20.2M | Buy |
717,912
+57,416
| +9% | +$1.61M | 0.02% | 490 |
|
|
2023
Q3 | $17.9M | Buy |
+660,496
| New | +$17.9M | 0.02% | 484 |
|